» Articles » PMID: 23836817

Animal Models for Studying Female Genital Tract Infection with Chlamydia Trachomatis

Overview
Journal Infect Immun
Date 2013 Jul 10
PMID 23836817
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Chlamydia trachomatis is a Gram-negative obligate intracellular bacterial pathogen. It is the leading cause of bacterial sexually transmitted disease in the world, with more than 100 million new cases of genital tract infections with C. trachomatis occurring each year. Animal models are indispensable for the study of C. trachomatis infections and the development and evaluation of candidate vaccines. In this paper, the most commonly used animal models to study female genital tract infections with C. trachomatis will be reviewed, namely, the mouse, guinea pig, and nonhuman primate models. Additionally, we will focus on the more recently developed pig model.

Citing Articles

in pigs: intriguing bacteria associated with sub-clinical carriage and clinical disease, and with zoonotic potential.

Hacker G Front Cell Dev Biol. 2024; 12:1301892.

PMID: 39206090 PMC: 11349706. DOI: 10.3389/fcell.2024.1301892.


Viral Vector-Based Vaccines Encoding CTH522 Induce Distinct Immune Responses in C57BL/6J and HLA Transgenic Mice.

Andreacchio G, Longo Y, Moreno Mascaraque S, Anandasothy K, Tofan S, Ozun E Vaccines (Basel). 2024; 12(8).

PMID: 39204067 PMC: 11360449. DOI: 10.3390/vaccines12080944.


Immunity to Sexually Transmitted Bacterial Infections of the Female Genital Tract: Toward Effective Vaccines.

Yount K, Darville T Vaccines (Basel). 2024; 12(8).

PMID: 39203989 PMC: 11359697. DOI: 10.3390/vaccines12080863.


A Simple and Versatile Method for Ex Vivo Monitoring of Goat Vaginal Mucosa Transduction by Viral Vector Vaccines.

Minesso S, Odigie A, Franceschi V, Cotti C, Cavirani S, Tempesta M Vaccines (Basel). 2024; 12(8).

PMID: 39203977 PMC: 11359855. DOI: 10.3390/vaccines12080851.


Infection of human organoids supports an intestinal niche for Chlamydia trachomatis.

Hovhannisyan P, Stelzner K, Keicher M, Paprotka K, Neyazi M, Pauzuolis M PLoS Pathog. 2024; 20(8):e1012144.

PMID: 39172739 PMC: 11340892. DOI: 10.1371/journal.ppat.1012144.


References
1.
Swenson C, Donegan E, Schachter J . Chlamydia trachomatis-induced salpingitis in mice. J Infect Dis. 1983; 148(6):1101-7. DOI: 10.1093/infdis/148.6.1101. View

2.
van de Laar M, Morre S . Chlamydia: a major challenge for public health. Euro Surveill. 2007; 12(10):E1-2. DOI: 10.2807/esm.12.10.00735-en. View

3.
de la Maza M, de la Maza L . A new computer model for estimating the impact of vaccination protocols and its application to the study of Chlamydia trachomatis genital infections. Vaccine. 1995; 13(1):119-27. DOI: 10.1016/0264-410x(95)80022-6. View

4.
Morre S, Lyons J, Ito Jr J . Murine models of Chlamydia trachomatis genital tract infection: use of mouse pneumonitis strain versus human strains. Infect Immun. 2001; 68(12):7209-11. PMC: 97843. DOI: 10.1128/IAI.68.12.7209-7211.2000. View

5.
Van Voorhis W, Barrett L, Sweeney Y, Kuo C, Patton D . Repeated Chlamydia trachomatis infection of Macaca nemestrina fallopian tubes produces a Th1-like cytokine response associated with fibrosis and scarring. Infect Immun. 1997; 65(6):2175-82. PMC: 175300. DOI: 10.1128/iai.65.6.2175-2182.1997. View